Adjunct Professor Craig Rayner has excelled across research and development sectors as a prominent medicine developer against global health threats. He has led international efforts against COVID-19, and been an advisor to industry, governments, the WHO and NGOs. As an experienced executive, he has built companies to multibillion dollar value and is committed to improving Australian R&D.